Lilly Says Updates To AHA/ACC/SCAI Clinical Guidelines Recommend Treatment With Effient For Patients With Acute Coronary Syndromes
11/18/2009 1:12:56 PM RTT News
|
Eli Lilly Says Effient Exhibits Greater Antiplatelet Activity In Type 2 Diabetes Mellitus Patients With CAD
11/15/2009 3:14:18 PM RTT News
|
Eli Lilly Says Steven Paul Will Retire As EVP, Science And Tech, President, Lilly Research Lab On Feb. 28 - Quick Facts
11/13/2009 9:22:35 AM RTT News
|
Eli Lilly Says Steven Paul To Retire As EVP, Science And Technology, President, Lilly Research Laboratories
11/13/2009 9:08:11 AM RTT News
|
Decision Resources Report: Key Agents From AstraZeneca, Eli Lilly, Pfizer And Bristol-Myers/Otsuka Will Lose Patent Exclusivity Starting In 2011
11/5/2009 8:13:23 AM RTT News
|
FDA Revises Byetta Label To Include Safety Information On Possible Kidney Problems - Quick Facts
11/2/2009 3:44:30 PM RTT News
|
Amylin Pharma, Eli Lilly And Co. Statement In Response To FDA's BYETTA Injection Update
11/2/2009 3:34:40 PM RTT News
|
Gilead Sciences, GlaxoSmithKline Reveals Phase IV Combination Study Of Pulmonary Hypertension Drugs - Update
11/2/2009 1:07:04 PM RTT News
|
Amylin And Eli Lilly's Diabetes Injection Gets FDA Nod For Stand-alone Use - Update
10/30/2009 9:02:14 PM RTT News
|
Amylin And Eli Lilly Says Their BYETTA Receives Approval For Expanded Use As First-Line Treatment For Type 2 Diabetes - Quick Facts
10/30/2009 8:29:26 PM RTT News
|